Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 485 | 370 | 1,165 | 473 | 1,164 |
| Receivables | 556 | 731 | 430 | 190 | 94 |
| Inventories | 5 | 13 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 52 |
| TOTAL | $1,108 | $1,235 | $1,715 | $804 | $1,385 |
| Non-Current Assets | |||||
| PPE Net | 480 | 28 | 35 | 46 | 7 |
| Intangibles | 85 | 733 | 903 | 1,073 | 763 |
| Other Non-Current Assets | 0 | 0 | 19 | 88 | 275 |
| TOTAL | $565 | $761 | $957 | $1,207 | $1,045 |
| Total Assets | $1,673 | $1,997 | $2,672 | $2,010 | $2,430 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 250 | 269 | N/A | N/A | N/A |
| Accrued Expenses | 83 | 46 | N/A | N/A | N/A |
| TOTAL | $476 | $315 | $367 | $744 | $1,145 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,765 | N/A | N/A | N/A | N/A |
| TOTAL | $2,074 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,550 | $315 | $367 | $744 | $1,145 |
| Shareholders' Equity | |||||
| Common Shares | 19,083 | 18,935 | 0 | 0 | 0 |
| Retained earnings | -23,655 | -20,550 | -17,746 | -13,864 | -9,052 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 720 |
| TOTAL | $-877 | $1,682 | $2,305 | $1,266 | $1,285 |
| Total Liabilities And Equity | $1,673 | $1,997 | $2,672 | $2,010 | $2,430 |